Log In Sign up
The largest database of trusted experimental protocols

Anti hla a2 fitc and apc

Manufactured by BD
Visit Supplier

Anti-HLA-A2-FITC and -APC are fluorescent-labeled antibodies that specifically bind to the HLA-A2 antigen, a major histocompatibility complex (MHC) class I molecule expressed on the surface of cells. These antibodies can be used in flow cytometry and other immunoassays to detect and quantify HLA-A2-positive cells.

Automatically generated - may contain errors

Lab products found in correlation

Anti cd8 fitc, by BD (2 mentions) Anti human mhc class 1 fitc antibodies, by BD (2 mentions) Anti cd138 apc, by BD (2 mentions)

Close spelling variants of this product

Anti-HLA-A2-FITC (2 citations)

2 protocols using anti hla a2 fitc and apc

1

Evaluation of Transduced T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transduced cells were evaluated for expression of the 1G4/α95:LY TCR using an APC-labeled NY-ESO-1157-165/HLA-A*02:01 tetramer (Immune Monitoring Facility, FHCRC) and anti-CD8-FITC (BD Biosciences). CD8+/tetramer+ population was isolated by fluorescence-activated cell sorting (FACS). Engraftment of U266/Luc in the blood, bone marrow, and selected organs of xenografted mice was assessed using anti-CD138-APC, anti-HLA-A2-FITC and -APC, and anti-human MHC class I-FITC antibodies (BD Biosciences).
Klippel Z.K., Chou J., Towlerton A.M., Voong L.N., Robbins P., Bensinger W.I, & Warren E.H. (2014). Immune escape from NY-ESO-1-specific T cell therapy via loss of heterozygosity in the MHC. Gene therapy, 21(3), 337-342.
+ Open protocol
+ Expand
2

Evaluation of Transduced T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transduced cells were evaluated for expression of the 1G4/α95:LY TCR using an APC-labeled NY-ESO-1157-165/HLA-A*02:01 tetramer (Immune Monitoring Facility, FHCRC) and anti-CD8-FITC (BD Biosciences). CD8+/tetramer+ population was isolated by fluorescence-activated cell sorting (FACS). Engraftment of U266/Luc in the blood, bone marrow, and selected organs of xenografted mice was assessed using anti-CD138-APC, anti-HLA-A2-FITC and -APC, and anti-human MHC class I-FITC antibodies (BD Biosciences).
Klippel Z.K., Chou J., Towlerton A.M., Voong L.N., Robbins P., Bensinger W.I, & Warren E.H. (2014). Immune escape from NY-ESO-1-specific T cell therapy via loss of heterozygosity in the MHC. Gene therapy, 21(3), 337-342.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!